https://www.pharmanation.in/news/india-bpal-tb-treatment-patent-rejected-hindi/ PharmaNationen 2026-10-29T09:50:59.704Z भारत में BPaL टीबी उपचार का पेटेंट आवेदन खारिज, मरीजों को क्या होगा फायदा? https://www.pharmanation.in/news/india-rejects-bpal-tb-drug-patent-application-2026/ PharmaNationen 2026-10-29T09:47:10.252Z India Rejects BPaL TB Drug Patent Application: Impact on Generic Medicines https://www.pharmanation.in/news/nucelion-pandorum-eye-therapies-prip-scheme-2026/ PharmaNationen 2026-10-29T02:52:35.041Z Nucelion and Pandorum Partner on Two Experimental Eye Therapies in India https://www.pharmanation.in/news/nppa-cancer-medicine-price-cuts-november-2026-hindinppa-cancer-medicine-price-cuts/ PharmaNationen 2026-10-29T01:48:46.243Z NPPA ने घटाईं 543 कैंसर दवा फॉर्मूलेशन की कीमतें, 9 नवंबर से नई दरें लागू https://www.pharmanation.in/news/nppa-cancer-medicine-price-cuts-november-2026/ PharmaNationen 2026-10-28T03:22:15.006Z NPPA Cuts Prices of 543 Cancer Medicine Formulations from November 9 https://www.pharmanation.in/news/cdsco-cancels-fatx-solution-registration-misleading-claims/ PharmaNationen 2026-10-27T16:05:14.602Z CDSCO Cancels FatX Solution Registration Over Misleading Claims: Key Lessons for India’s Cosmetic Industry https://www.pharmanation.in/news/cdsco-approves-zytorvi-toripalimab-oesophageal-cancer-india/ PharmaNationen 2026-10-27T15:05:46.974Z CDSCO Approves Zytorvi for Advanced Oesophageal Cancer in India